NDC Package 71161-133-01 Mometasone Furoate

Implant - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71161-133-01
Package Description:
1 POUCH in 1 CARTON / 1 IMPLANT in 1 POUCH
Product Code:
Non-Proprietary Name:
Mometasone Furoate
Substance Name:
Mometasone Furoate
Usage Information:
Mometasone is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school.
11-Digit NDC Billing Format:
71161013301
Product Type:
Drug For Further Processing
Labeler Name:
Synergy Health, Llc
Dosage Form:
Implant - A material containing drug intended to be inserted securely of deeply in a living site for growth, slow release, or formation of an organic union.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
02-01-2018
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71161-133-01?

The NDC Packaged Code 71161-133-01 is assigned to an UNFINISHED drug package of 1 pouch in 1 carton / 1 implant in 1 pouch of Mometasone Furoate, drug for further processing labeled by Synergy Health, Llc. The product's dosage form is implant and is administered via form.

Is NDC 71161-133 included in the NDC Directory?

Yes, Mometasone Furoate is an UNFINISHED PRODUCT with code 71161-133 that is active and included in the NDC Directory. The product was first marketed by Synergy Health, Llc on February 01, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 71161-133-01?

The 11-digit format is 71161013301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-271161-133-015-4-271161-0133-01